medigraphic.com
ISSN 0016-3813 (Print)

2011, Number 5

<< Back Next >>

Gac Med Mex 2011; 147 (5)

First case of HIV-1 subtype C infection in Mexico

Rivera-Morales LG, Luna-Cruz IE, Ramos-Alfano G, Rosas-Taraco AG, Ramos-Jiménez J, Palacios-Saucedo GC, Vázquez-Guillén JM, Franco-Molina MA,Tamez-Guerra R, Rodríguez-Padilla C

Language: Spanish
References: 28
Page: 424-428
PDF size: 122.59 Kb.


ABSTRACT

We herein report the first case of HIV-1 subtype C described in Mexico, which was detected in a South African patient who died in Mexico of an AIDS-related non-Hodgkin lymphoma. Although HIV-1 subtype B is the predominant virus circulating in Mexico, the case reported highlights the importance of molecular monitoring of the spreading of HIV-1 subtypes.


REFERENCES

  1. UNAIDS. 2009 AIDS Epidemic Update. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2009. Disponible en: http://www.unaids.org/en/

  2. Secretaría de Salud, México. 2009. Casos de SIDA en México (Cifras a 31 de marzo de 2009). Centro Nacional para la Prevención y el Control del VIH/SIDA (CENSIDA). Disponible en: http://www.censida.salud.gob.mx/

  3. Magis C, Hernández M. Epidemiología del SIDA en México. En: Córdova JA, Ponce de León S, Valdespino JL (eds). 25 Años de SIDA en México. Logros, Desaciertos y Retos. México: Secretaría de Salud; 2008. p. 85-103.

  4. Buonaguro L, Tornesello ML, Buonaguro FM. Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications. J Virol. 2007;81:10209-19.

  5. Plantier JC, Leoz M, Dickerson JE, et al. A new human immunodeficiency virus derived from gorillas. Nat Med. 2009;15:871-2.

  6. Kuiken C, Foley B, Marx P, et al (eds). HIV sequence compendium 2009. Published by Theoretical Biology and Biophysics Group, Los Alamos National Laboratory; 2009.

  7. Novitsky VA, Rybak N, McLane MF, et al. Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design. J Virol. 2001;75:9210-28.

  8. Novitsky VA, Smith UR, Gilbert P, et al. Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? J Virol. 2002;76:5435-51.

  9. Leal E, Villanova FE. Diversity of HIV-1 subtype B: implications to the origin of BF recombinants. PLoS One. 2010;5(7):e11833.

  10. Brookmeyer R, Mehendale SM, Pelz RK, et al. Estimating the rate of occurrence of new HIV infections using serial prevalence surveys: the epidemic in India. AIDS. 1996;10:924-5.

  11. Esparza J, Bhamarapravati N. Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how? Lancet. 2000;355:2061-6.

  12. Essex M. Human immunodeficiency viruses in the developing world. Adv Virus Res. 1999;53:71-88.

  13. Hu DJ, Dondero TJ, Rayfield MA, et al. The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA. 1996;275:210-6.

  14. Lole KS, Bollinger RC, Paranjape RS, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73:152-60.

  15. Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS. 2006;20:13-23.

  16. Eyzaguirre L, Brouwer KC, Nadai Y, et al. First molecular surveillance report of HIV type 1 in injecting drug users and female sex workers along the U.S.-Mexico border. AIDS Res Hum Retroviruses. 2007;23:331-4.

  17. Rivera-Morales LG, Novitsky VA, Trujillo JR, et al. The molecular epidemiology of HIV type 1 of men in Mexico. AIDS Res Hum Retroviruses. 2001;17:87-92.

  18. Delwart EL, Shpaer EG, Louwagie J, et al. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science. 1993;262:1257-61.

  19. Novitsky VA, Montano MA, Essex M. Molecular epidemiology of an HIV-1 subtype A subcluster among injection drug users in the Southern Ukraine. AIDS Res Hum Retroviruses. 1998;14:1079-85.

  20. Larkin MA, Blackshields G, Brown NP, et al. Clustal W and clustal X version 2.0. Bioinformatics. 2007;23:2947-8.

  21. Papathanasopoulos MA, Vardas E, Wallis C, et al. Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS vaccine integrated project (AVIP) study. AIDS Res Hum Retroviruses. 2010;26:705-9.

  22. Field V, Gautret P, Schlagenhauf P, et al. Travel and migration associated infectious diseases morbidity in Europe, 2008. BMC Infect Dis. 2010;10:330.

  23. Aguayo N, Laguna-Torres VA, Villafane M, et al. Epidemiological and molecular characteristics of HIV-1 infection among female commercial sex workers, men who have sex with men and people living with AIDS in Paraguay. Rev Soc Bras Med Trop. 2008;41:225-31.

  24. Rangel HR, Garzaro D, Gutiérrez CR, et al. HIV diversity in Venezuela: predominance of HIV type 1 subtype B and genomic characterization of non-B variants. AIDS Res Hum Retroviruses. 2009;25:347-50.

  25. Sánchez GI, Bautista CT, Eyzaguirre LM, et al. Short report: Molecular epidemiology of human immunodeficiency virus–infected individuals in Medellin, Colombia. Am J Trop Med Hyg. 2006;74:674-7.

  26. Nadai Y, Eyzaguirre LM, Sill A, et al. HIV-1 epidemic in the Caribbean is dominated by subtype B. PLoS One. 2009;4:e4814.

  27. Fontella R, Soares MA, Schrago CG. On the origin of HIV-1 subtype C in South America. AIDS. 2008;22:2001-11.

  28. Montano SM, Sánchez JL, Laguna-Torres A, et al. Prevalences, genotypes, and risk factors for HIV transmission in South America. J Acquir Immune Defic Syndr. 2005;40:57-64.




2020     |     www.medigraphic.com